Takeda’s bleeding disorder drug Veyvondi backed for NHS useNHS England has recommended that patients with von Willebrand disease (VWD) be treated with Takeda’s Veyvondi, making it Share XTakeda’s bleeding disorder drug Veyvondi backed for NHS usehttps://pharmaphorum.com/news/takedas-bleeding-disorder-drug-veyvondi-backed-for-nhs-use/
Shire’s von Willebrand disease therapy Veyvondi approved in EUThe European Commission has approved Shire’s Veyvondi for treatment of the bleeding disorder von Willebrand disease (VWD). VWD Share XShire’s von Willebrand disease therapy Veyvondi approved in EUhttps://pharmaphorum.com/news/shires-von-willebrand-disease-therapy-veyvondi-approved-in-eu/
